Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John Ip, M.D.
Thoracic & Cardiovascular Healthcare Foundation, Lansing, MI
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
80 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Facility name not stated
Wahroonga, Australia
- Facility name not stated
Montreal, Quebec, Canada
- Facility name not stated
Sherbrooke, Quebec, Canada
- Facility name not stated
Aarhus, Denmark
- Facility name not stated
Tübingen, Germany
- Facility name not stated
Villingen, Germany
- Facility name not stated
Birmingham, United Kingdom
- Facility name not stated
Phoenix, Arizona, United States
- Facility name not stated
Scottsdale, Arizona, United States
- Facility name not stated
Anaheim, California, United States
- Facility name not stated
Fremont, California, United States
- Facility name not stated
Santa Barbara, California, United States
- Facility name not stated
Torrance, California, United States
- Facility name not stated
Ventura, California, United States
- Facility name not stated
Aurora, Colorado, United States
- Facility name not stated
Boulder, Colorado, United States
- Facility name not stated
Newark, Delaware, United States
- Facility name not stated
Davenport, Florida, United States
- Facility name not stated
Daytona Beach, Florida, United States
- Facility name not stated
Kissimmee, Florida, United States
- Facility name not stated
Melbourne, Florida, United States
- Facility name not stated
Sarasota, Florida, United States
- Facility name not stated
St. Petersburg, Florida, United States
- Facility name not stated
Zephyrhills, Florida, United States
- Facility name not stated
Chicago, Illinois, United States
- Facility name not stated
Elk Grove Village, Illinois, United States
- Facility name not stated
Maywood, Illinois, United States
- Facility name not stated
Fort Wayne, Indiana, United States
- Facility name not stated
Valparaiso, Indiana, United States
- Facility name not stated
Shawnee Mission, Kansas, United States
- Facility name not stated
Lexington, Kentucky, United States
- Facility name not stated
Louisville, Kentucky, United States
- Facility name not stated
Owensboro, Kentucky, United States
- Facility name not stated
Hammond, Louisiana, United States
- Facility name not stated
Lafayette, Louisiana, United States
- Facility name not stated
New Orleans, Louisiana, United States
- Facility name not stated
Bangor, Maine, United States
- Facility name not stated
Lewiston, Maine, United States
- Facility name not stated
Cumberland, Maryland, United States
- Facility name not stated
Boston, Massachusetts, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Feb 2008
- Primary completion
- 30 Jun 2013
- Completion
- 30 Jun 2013
- Last update posted
- 5 Dec 2017
- Registered enrollment
- 2,718
- Registry id
- NCT00559988
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.